Durgical
EN
Open the app

Growing and measuring viruses

  • General virology

How laboratories grow viruses in living cells, recognise them by the damage they cause, count them and handle them safely.

Updated

What it is

Viruses multiply only inside living cells, so laboratories grow them in cell cultures, embryonated eggs or, rarely, animals. Infection is recognised by changes in the cells and counted with assays that measure infectious units or physical particles. Clinical diagnosis now relies mostly on molecular tests; culture remains important for vaccines, research, drug testing and public health characterisation of strains.

Key facts

  • Primary cell cultures come straight from tissue and survive few passages; diploid cell strains (human fibroblasts) last a limited number of divisions; continuous cell lines (often from tumours) grow indefinitely
  • Embryonated hen's eggs are used to grow influenza virus, including for much vaccine production
  • Cytopathic effect (CPE): rounding, detachment, syncytia or inclusions visible under the microscope; its speed and pattern hint at the virus
  • Haemadsorption: red cells stick to cells infected by viruses that put haemagglutinin on the cell surface (influenza, parainfluenza), even without CPE
  • Shell-vial culture: centrifuging the sample onto cells and staining early viral antigen gives a result in days instead of weeks (classically CMV)
  • Viral culture is slow for clinical decisions; molecular tests detect nucleic acid in hours but do not prove that infectious virus is present

Step by step

  1. Grow a confluent single layer of susceptible cells
  2. Add serial ten-fold dilutions of the sample
  3. Let the virus adsorb, then cover the cells with a semi-solid overlay so new virus spreads only to neighbouring cells
  4. Incubate until clear zones of dead cells (plaques) form
  5. Fix and stain the layer, count the plaques and multiply by the dilution to get the titre

Ways to measure virus

MethodWhat it measuresTypical use
Plaque assayInfectious units (plaque-forming units): each plaque starts from one infectious particleTitre of stocks, neutralising antibodies
50% tissue culture infectious dose (TCID50)Dilution that infects half the culturesViruses that do not form plaques
HaemagglutinationParticles able to clump red cells, infectious or notQuick count of influenza and other haemagglutinating viruses
Haemagglutination inhibitionAntibodies that block haemagglutinationTyping influenza strains, measuring immunity
Electron microscopyTotal particles and their shapeResearch, outbreak investigation
Quantitative PCRGenome copiesViral load in patients (HIV, hepatitis B and C, CMV)

In the lab

  • Purification: differential and density-gradient ultracentrifugation separate virions from cell debris
  • Biosafety: every procedure starts with a risk assessment that matches controls to the agent and the activity
  • Most clinical viruses are handled at biosafety level 2; culture of agents such as highly pathogenic avian influenza needs level 3; Ebola, Marburg and Lassa need level 4
  • Use a biological safety cabinet for anything that makes aerosols; never culture a suspected high-consequence virus in a routine laboratory

Common traps

  • A positive PCR proves that infectious virus is present: PCR finds nucleic acid, which can come from dead or defective virus; only culture shows live, replicating virus.
  • A high haemagglutination titre means many infectious virions: it counts all particles that clump red cells, including defective ones.
  • No cytopathic effect means no virus in the culture: influenza and parainfluenza can be present without it and are shown by haemadsorption.
  • Viral culture is the routine way to diagnose infections: it is too slow; nucleic acid tests have replaced it, and culture is kept for vaccines, research, drug testing and strain characterisation.
  • Any microbiology laboratory can culture a suspected Ebola sample: Ebola, Marburg and Lassa need biosafety level 4, and suspected high-consequence viruses are never cultured in a routine laboratory.

Test yourself

Think of the answer, then tap the question to see it.

Cells inoculated with a 10^-6 dilution of a virus stock show 30 plaques. What does each plaque represent, and how is the titre found?

Each plaque began from one infectious particle. The titre is the plaque count multiplied by the dilution factor, here 30 × 10^6 infectious units in the volume plated.

A patient's PCR for a respiratory virus is still positive three weeks after recovery. Does that mean the patient is still infectious?

Not necessarily. PCR detects viral nucleic acid, which can persist from non-infectious virus; only culture of live virus would show ongoing infectivity.

A respiratory sample on cell culture shows no cytopathic effect, but red cells added to the culture stick to the cells. What does this suggest?

Haemadsorption: the cells display viral haemagglutinin, pointing to influenza or parainfluenza virus, even before any cytopathic effect.

A virus kills cultured cells but does not form countable plaques. Which assay can give its titre, and what does the endpoint mean?

The 50% tissue culture infectious dose (TCID50): the dilution of sample that infects half of the inoculated cultures.

Why does shell-vial culture give a CMV result in days rather than weeks?

The sample is centrifuged onto the cells to boost infection, and early viral antigen is stained before any cytopathic effect has time to appear.

Add to my cards (5)

Connections

← General microbiology

Educational content on microorganisms; not a treatment guide and no substitute for a health professional's advice. No doses are given.

Sources: Overview of Influenza Testing Methods (CDC, 2025); Laboratory biosafety manual, 4th edition (World Health Organization (WHO), 2020); Biosafety in Microbiological and Biomedical Laboratories (BMBL) 6th Edition (CDC and NIH, 2020).

Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake

Representative model, for educational purposes only.